help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Correction for Lebovitz et al., J Clin Endocrinol Metab 86 (1) 280-288.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
The Journal of Clinical Endocrinology & Metabolism Vol. 86, No. 4 1659
Copyright © 2001 by The Endocrine Society

Announcements

Erratum

In the article "Rosiglitazone monotherapy is effective in patients with type 2 diabetes" by Harold E. Lebovitz, Jo F. Dole, Rita Patwardhan, Elizabeth B. Rappaport, and Martin I. Freed for the Rosiglitazone Clinical Trials Study Group (The Journal of Clinical Endocrinology & Metabolism 86:280–288), the dosages of rosiglitazone were incorrectly stated in Tables 1–7. The correct doses of rosiglitazone are 2 mg and 4 mg bd and not 2 mg and 4 mg daily.\.




This article has been cited by other articles:


Home page
 Diabetes CareHome page
R. Kahn, J. Buse, E. Ferrannini, and M. Stern
The Metabolic Syndrome: Time for a Critical Appraisal: Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes
Diabetes Care, September 1, 2005; 28(9): 2289 - 2304.
[Abstract] [Full Text] [PDF]

Home page
 CMAJHome page
P. Madan
Effect of thiazolidinediones on lipid profile
Can. Med. Assoc. J., August 16, 2005; 173(4): 344 - 344.
[Full Text] [PDF]

Home page
 CMAJHome page
A. Y.Y. Cheng and I. G. Fantus
Effect of thiazolidinediones on lipid profile
Can. Med. Assoc. J., August 16, 2005; 173(4): 344 - 345.
[Full Text] [PDF]

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals